Walmart (WMT.N): Walmart U.S. comparable sales expected to receive roughly a
50bps boost from GLP-1 drugs in FY27; the effect was about 100bps in FY25 and
FY26.
2026-08-20
Walmart (WMT.N): Walmart U.S. comparable sales expected to receive roughly a
50bps boost from GLP-1 drugs in FY27; the effect was about 100bps in FY25 and
FY26.